Showing results (201-210 of 280) with videos related to

Sort By:
Pageof 28
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 7, 2015
T-cell subsets in peripheral blood and tumors of patients treated with oncolytic adenovirusesKristian Taipale, Ilkka Liikanen, Juuso Juhila, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 25, 2002
Gene transfer to ovarian cancer versus normal tissues with fiber-modified adenovirusesAnna Kanerva, Minghui Wang, Gerd J Bauerschmitz, et al.
Molecular Pharmaceutics|October 23, 2010
Safety of glucocorticoids in cancer patients treated with oncolytic adenovirusesMaria Rajecki, Mari Raki, Sophie Escutenaire, et al.
Molecular Therapy Oncolytics|March 28, 2017
Oncolytic Adenoviruses Armed with Tumor Necrosis Factor Alpha and Interleukin-2 Enable Successful Adoptive Cell TherapyRiikka Havunen, Mikko Siurala, Suvi Sorsa, et al.
Molecular Cancer Therapeutics|February 20, 2007
Treatment of prostate cancer with Ad5/3Delta24hCG allows non-invasive detection of the magnitude and persistence of virus replication in vivoMaria Rajecki, Anna Kanerva, Ulf-Håkan Stenman, et al.
Human Gene Therapy|January 20, 2021
Oncolytic Adenovirus ORCA-010 Activates Proinflammatory Myeloid Cells and Facilitates T Cell Recruitment and Activation by PD-1 Blockade in MelanomaIoanna Milenova, Marta Lopez Gonzalez, Dafne C A Quixabeira, et al.
The Journal of Gene Medicine|April 15, 2003
The secretory leukoprotease inhibitor (SLPI) promoter for ovarian cancer gene therapyShannon D Barker, Candace J Coolidge, Anna Kanerva, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 28, 2011
Induction of interferon pathways mediates in vivo resistance to oncolytic adenovirusIlkka Liikanen, Vladia Monsurrò, Laura Ahtiainen, et al.
Cancer Research|July 18, 2008
Tissue-specific promoters active in CD44+CD24-/low breast cancer cellsGerd J Bauerschmitz, Tuuli Ranki, Lotta Kangasniemi, et al.
Gastroenterology|September 7, 2005
Gene-expression profiling predicts recurrence in Dukes' C colorectal cancerDiego Arango, Paivi Laiho, Antti Kokko, et al.
Pageof 28